Agilent Technologies, Inc. (NYSE:A) is one of the 10 Best Diagnostics and Research Stocks to Buy According to Analysts. Agilent Technologies (A) to Acquire Biocare Medical for $950M On March 9, 2026, Agilent Technologies, Inc. (NYSE:A) announced entering into a definitive agreement to acquire Biocare Medical for $950 million. The all-cash deal combines Biocare’s high-growth portfolio of immunohistochemistry (IHC) antibodies and reagents with Agilent Technologies, Inc. (NYSE:A)’s existing pathology divisi ...